27N0
Cannovum Cannabis AG engages in the manufacturing, wholesaling, and importing of medical cannabis products in Berlin. It also focuses on the import of medical cannabis and medical-scientific education, as well as distribution for facilitated access to cannabis-based therapies. The company was formerly known as Cannovum AG and changed its name to Cannovum Cannabis AG in April 2023. Cannovum Cannab… Read more
Market Cap & Net Worth: 27N0 (27N0)
27N0 (XETRA:27N0) has a market capitalization of $1.13 Million (€1.10 Million) as of March 18, 2026. Listed on the XETRA stock exchange, this Germany-based company holds position #46171 globally and #7670 in its home market, demonstrating a -2.06% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying 27N0's stock price €0.48 by its total outstanding shares 2311140 (2.31 Million).
27N0 Market Cap History: 2025 to 2026
27N0's market capitalization history from 2025 to 2026. Data shows growth from $1.06 Million to $1.13 Million (0.00% CAGR).
27N0 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how 27N0's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 27N0 by Market Capitalization
Companies near 27N0 in the global market cap rankings as of March 18, 2026.
Key companies related to 27N0 by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
27N0 Historical Marketcap From 2025 to 2026
Between 2025 and today, 27N0's market cap moved from $1.06 Million to $ 1.13 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.13 Million | +6.03% |
| 2025 | €1.06 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of 27N0 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.13 Million USD |
| MoneyControl | $1.13 Million USD |
| MarketWatch | $1.13 Million USD |
| marketcap.company | $1.13 Million USD |
| Reuters | $1.13 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.